Medical Doctor Program year 2025 Reported 2020–2025 Source: CMS Open Payments, 2026 publication

Shaan Raza

Neurological Surgery Houston, TX Medical Doctor

NPI 1992842751 CMS profile 648086

1515 Holcombe Blvd, The University Of Texas M.D. Anderson Cancer Center, Houston, TX 77030

Open in the dashboard

General payments

$66,126

108 records reported · program years 2020–2025

Research payments

$0

Paid to them · None reported · program years 2020–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$72,193 paid to institutions, not to them · program years 2021–2022

Through program year 2025, Shaan Raza of Houston, TX is reported in the CMS Open Payments database as having received $66,126 across 108 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $72,193 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 88th percentile of Neurological Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $27,106 47
2024 General $3,266 20
2023 General $28,590 26
2022 General $3,596 11
2020 General $3,568 4

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Shaan Raza
  • Neurological Surgery median
  • Middle half of Neurological Surgery
  • National median

In program year 2025, general payments to Shaan Raza were reported at $27,106. Among 5,467 Neurological Surgery profiles paid that year, the median was $596 and the middle half received between $159 and $3,102.

Show as a table
Year Shaan Raza Neurological Surgery median Middle half National median
2019 $0 $582 $138–$3,006 $163
2020 $3,568 $294 $76–$2,174 $114
2021 $0 $387 $105–$2,432 $132
2022 $3,596 $542 $139–$2,989 $149
2023 $28,590 $534 $145–$2,697 $160
2024 $3,266 $574 $155–$3,046 $164
2025 $27,106 $596 $159–$3,102 $169

Breakdown

Who paid General payments · program years 2020–2025
  1. Stryker Corporation $39,459 44 payments
  2. Medtronic, Inc. $22,683 57 payments
  3. B. Braun Medical UK Ltd. $3,568 4 payments
  4. Zimmer Biomet Holdings, Inc. $150 1 payment
  5. DePuy Synthes Sales Inc. $150 1 payment
  6. Kyowa Kirin, Inc. $116 1 payment

Every payment, record by record

What the payments were for General payments · program years 2020–2025
  1. Consulting Fee $32,929 11 payments
  2. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $17,920 1 payment
  3. Travel and Lodging $12,684 49 payments
  4. Food and Beverage $2,593 47 payments
Products named General payments · program years 2020–2025
  1. CORE $28,865 26 payments
  2. SONOPET IQ $23,900 3 payments
  3. MIDAS REX $21,258 45 payments
  4. SPETZLER-MALIS $6,788 5 payments
  5. NONE $3,568 4 payments
  6. MAZOR X SYSTEM $1,364 11 payments
  7. NICO AUTOMATED PRESERVATION SYSTEM $541 1 payment
  8. NICO BRAINPATH $541 1 payment
  9. NICO SECUREHOLD $541 1 payment
  10. NICO BRAINPATH APPROACH $541 1 payment
  11. Other $1,204 7 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 32 billing codes

Paid by Medicare

$91,866

Medicare's payments for the services billed

Medicare patients

75

Average age 71

Services billed

159

38 women, 37 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 43%
Diabetes 31%
Ischemic heart disease 29%
Cancer 29%
Osteoporosis 27%
Depression 24%
Chronic kidney disease 23%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

108 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Neurological Surgery in Texas

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record